SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062274
Filing Date
2023-11-13
Accepted
2023-11-09 20:27:16
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsbx-20230930.htm   iXBRL 10-Q 3707323
2 EX-31.1 tsbx-ex31_1.htm EX-31.1 14232
3 EX-31.2 tsbx-ex31_2.htm EX-31.2 14538
4 EX-32.1 tsbx-ex32_1.htm EX-32.1 9714
5 GRAPHIC img126533469_0.jpg GRAPHIC 77841
  Complete submission text file 0000950170-23-062274.txt   11972883

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsbx-20230930_lab.xml EX-101.LAB 520804
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsbx-20230930_pre.xml EX-101.PRE 391116
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tsbx-20230930_def.xml EX-101.DEF 311417
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tsbx-20230930_cal.xml EX-101.CAL 52103
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsbx-20230930.xsd EX-101.SCH 64880
65 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20230930_htm.xml XML 2124059
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41747 | Film No.: 231394324
SIC: 2836 Biological Products, (No Diagnostic Substances)